{
    "@context": "https://odca.tech/v1",
    "name": "Vaccination Credential",
    "type": "spec/overlay/entry/1.0",
    "description": "A form to be used for verifiable COVID-19 vaccination credentials for basic interoperability",
    "classification": "",
    "issued_by": "OCA-FHIR-CLI, v0.1",
    "role": "Holder",
    "purpose": "Claim",
    "schema_base": "hl:zQmVd9qe8WV5TjeAjHa7K97g9goRuZvsEmYnAEg8nZa1DN3",
    "attr_information":  {"disease":"Condition post COVID-19|Syndrome inflammatoire multisystémique associé à COVID-19|Antécédents personnels de COVID-19","vaccineDescription":"Produit vaccinal contenant uniquement un antigène du coronavirus 2 du syndrome respiratoire aigu sévère (médicament)|Produit vaccinal contenant uniquement de l'acide ribonucléique messager du coronavirus 2 du syndrome respiratoire aigu sévère (médicament)|Produit vaccinal contenant l'antigène du coronavirus 2 du syndrome respiratoire aigu sévère ou coronavirus du syndrome respiratoire aigu sévère Acide ribonucléique messager 2 (médicament)","vaccineType":"Vaccin ARNm COVID-19|Vaccin antigénique COVID-19","medicinalProductName":"Vaccin Moderna COVID-19|Vaccin Pfizer-Biontech COVID-19|Vaccin AstraZeneca COVID-19|Vaccin Janssen COVID-19","cvxCode":"Code CVX du vaccin Moderna|Code CVX du vaccin Pfizer-Biontech|Code CVX du vaccin AstraZeneca|Code CVX du vaccin Janssen","marketingAuthorizationHolder":"Moderna US, Inc.|Pfizer, Inc.|AstraZeneca Pharmaceuticals LP|Janssen Products, LP","stateOfVaccination":"L'Alberta|La Colombie-Britannique|Le Manitoba|Le Nouveau-Brunswick|La Terre-Neuve-et-Labrador|Les Territoires du Nord-Ouest|La Nouvelle-Écosse|Le Nunavut|L'Ontario|Île-du-Prince-Édouard|Le Québec|La Saskatchewan|Le Yukon","countryOfVaccination":"Canada (le)"}
}